Dates of Event:
8th July 2019 – 12th July 2019
This call is open only for Candidates from the Eurolife-Member Universities
This year Eurolife will fund 9 grants towards students and researchers from Eurolife institutions, wishing to join the 5-day Eurolife Summer School on immunotherapy, vaccinology, microbiota interventions and drug development for infectious and hyperinflammatory diseases, including novel therapeutic approaches such as host-directed personalized therapies.
Join the Eurolife Summer School to increase your knowledge on human and animal infectious diseases, immunotherapy for inflammatory diseases, microbiota interventions and host-directed therapies against infectious diseases, clinical trials as well the industrial production of vaccines and antimicrobial therapies. In result of your participation, you are expected to gain an understanding of vaccine design and immunotherapy, preclinical testing, and clinical evaluation.
Who can apply
This Eurolife School is particularly suitable for (bio)medical Master students, PhD students, as well as early stage post-doctoral scientists who are interested in one or more of the following; immunology, microbiology and metabolism.
While the course is directed at PhD/graduate students, scientists working in industry may also wish to apply to gain latest insights into immunotherapy and vaccinology.
There is a total of 30 places avaialble for this Summer School.
- Interested students/researchers from non-Eurolife Member Universities can apply to join this Eurolife Summer School according to the standard procedure and fee of €200 (see website of the Summer School).
– free for selected students from Eurolife Consortium institutions nominated for the Eurolife Summer School grant (9 grants available, preferably 1 per Eurolife institution).
– all other selected Candidates – €200
*Candidates are expected to organise and fund their travel to- and from- Leiden.
*Meals and accommodation are included in the participation fee.
How to apply
Required documents: Application Form, CV, Reference Letter from the supervisor and Motivation Letter (200-300 words presenting some background to the research the Candidate is involved in, and predicted impact of the participation on the Candidate’s academic/professional career).
Candidates should complete the Application Form and together with the annexed documents, email the ZIP FILE to the Eurolife General Coordinator on email@example.com Please ensure to include the name of the Eurolife Summer School (Immune modulation in human and animal infections) in the subject of your email.
Only applications submitted by email will be considered.
Deadline for Applications: 17:00 (CET) 5th May 2019
Successful applicants will be notified by the 1st June 2019
More about the event
Leiden University Medical Center -Center of Infectious Diseases
- Dr. Hermelijn Smits
- Dr. Marjolein Kikkert
- Prof dr. Ed Kuijper
- Prof dr. Ron Hokke
- Prof dr. Leo Visser
- Prof dr. Tom Ottenhoff
University of Edinburgh
- Dr. David Dockrell
- Prof. dr. Ross Fitzgerald
- Prof. dr Mark Stevens
Summary of the themes covered by the Eurolife Summer School
- Introduction to current standards in (emerging) infectious disease control
- The molecular mechanisms of immune modulation by infectious agents
- Antimicrobial resistance in bacteria, viruses, parasites and fungi and new approaches for treatment of drug resistant microorganisms
- The role of microbiome in health and disease, both animal and human
- Controlled human and (large) animal infection models (combined with entrepreneurship)
- Infectious disease vaccine design and preclinical validation
- Novel host-directed and personalised therapies for infectious and immune diseases
- Develop a research proposal in small tutor-guided sessions on a topic related the themes of the Summer School
- To develop an overall understanding of immune modulation by pathogens and commensals and the balance between immune exploitation and immune training, including the role of the microbiota (benefit).
- To give participants the knowledge and skills to design and test a vaccine/immunotherapy for a given infection or disease, including understanding of the immune responses involved, role of adjuvant, target antigen(s) and immune cells.
- To understand the role and application of controlled human infections in vaccine and/or immunotherapy development.
- To impart knowledge and understanding of manufacture across a spectrum of different vaccines, including the requirements of GMP (Good Manufacturing Practice).
- Translate the acquired knowledge into novel research proposals on themes related to One Health.